What you need to know about Orimeten
Please read this carefully before you start to take your tablets. This leaflet does not contain the complete information about your tablets. If you have any questions or are not sure about anything ask your doctor or pharmacist.
Orimeten contains a substance called aminoglutethimide. Aminoglutethimide affects the production of certain hormones in the body. It is used to treat a number of conditions including breast and prostate disorders and Cushing's syndrome. Ask your doctor if you would like further information.
Things to remember about Orimeten
- Make sure it is safe for you to take Orimeten (see the back of this leaflet).
- Take your tablets as instructed by your doctor and read the label on the carton.
- These tablets may cause unwanted effects in some people. You can find information about them on the back of this leaflet.
- Keep taking your tablets until your doctor tells you to stop.
- Keep your tablets in their original container in a cool, dry place. Keep all medicines out of reach of children.
- Remember to return any unused tablets to your pharmacist.
This leaflet has been prepared for patients as part of our 'Partners in Health Care' theme by:–
|
Ciba Laboratories, Horsham, West Sussex, England.
|
PL 0008/0147
PA 28/40/1
|
Made by Ciba-Geigy Limited, Basle, Switzerland.
Copyright © Ciba-Geigy PLC November 1991 747S71a
Orimeten affects the production of certain hormones in the body. It is used to treat a number of conditions including breast and prostate disorders and Cushing's syndrome. Ask your doctor if you would like further information.
What's in your medicine
- Orimeten tablets contain 250mg of aminoglutethimide.
Before taking your medicine
- Are you pregnant, trying to become pregnant or breast-feeding?
If the answer to any part of this question is YES, DO NOT take the tablets without talking to your doctor again.
- Are you diabetic and taking anti-diabetic tablets?
- Are you taking medicines for 'thinning the blood' (anticoagulants)?
- Are you taking any other medicines which your doctor does not know about?
- If the answer to any of these questions is YES, tell your doctor or pharmacist.
Taking your medicine
- It is important to take your tablets at the right times. You must take them as instructed by your doctor. The label will tell you how many to take and how often. If it does not, or you are not sure, ask your doctor or pharmacist.
- You should swallow the tablets with a drink of water
- If you forget to take a dose, take it as soon as you remember Then go on as before. DO NOT take a double dose.
- Keep taking the tablets until your doctor tells you to stop.
- Your doctor may give you some other tablets (for example, hydrocortisone tablets) to take with your Orimeten. If so, take them as instructed by your doctor
- If you accidentally take too many Orimeten tablets tell your doctor immediately or contact your nearest hospital casualty department
After taking your medicine
These tablets sometimes cause unwanted effects in some people. If you get any of the following tell your doctor
- Skin rash.
- Persistent sore throat or high temperature.
- Unexplained bruising.
- Breathlessness or wheezing.
- Other effects which may occur include:
- Upset stomach.
- Dizziness, sleepiness or unusual tiredness
These effects are often mild and may wear off after a few days' treatment. If they are severe or last for more than a few days, tell your doctor. Also, if your tablets upset you in any other way, tell your doctor
Precautions
- When you start taking Orimeten, your doctor may want you to have a number of blood tests. This is quite usual and nothing to worry about.
- If you feel dizzy or sleepy when you start to take these tablets, do not drive or operate machinery until these effects have worn off.
- Check with your doctor or pharmacist before taking any other medicines whilst you are on Orimeten.
- REMEMBER: this medicine is for YOU. Only a doctor can prescribe it for you. Never give it to someone else. It may harm them even if they have the same symptoms as you .
This leaflet is produced in accordance with guidance issued by the Association of the British Pharmaceutical Industry The information in it applies only to Orimeten.